# The Jaw-Locking Case of a Missed Tetanus Booster

**Authors:** Erica Westlake, Katherine Billings, Ann McMoran, Katherine Selman, Sarab Sodhi

PMC · DOI: 10.5811/cpcem.33516 · Clinical Practice and Cases in Emergency Medicine · 2025-02-26

## TL;DR

A young man with a history of not receiving a tetanus booster recently developed severe symptoms, which were diagnosed and successfully treated as tetanus.

## Contribution

This case highlights the importance of tetanus booster adherence and the clinical management of suspected tetanus in emergency settings.

## Key findings

- The patient's symptoms resolved after treatment with immunoglobulin, tetanus immunization, and antibiotics.
- The case confirms the diagnostic and therapeutic approach for tetanus in the absence of immediate diagnostic tests.
- Rhabdomyolysis and elevated lactate were observed as complications during the clinical course.

## Abstract

Tetanus is a now rare disease due to the widespread administration of scheduled and prophylactic vaccines, making it exceptionally uncommon to appear in many emergency departments. Clinical suspicion alone is used to make the diagnosis as there are currently no immediately available diagnostic tests available to the clinician. If left unrecognized and untreated, however, tetanus can lead to airway compromise and death.

We report a case of a young male who presented to the emergency department with intermittent full body spasms and stiffness of the masseter muscles in the setting of recent assaults and lacerations weeks prior who had not received tetanus since 2008. Immediate calls were placed to infectious disease consultants and the patient was treated with intravenous immunoglobulin, tetanus immunization, metronidazole, and ceftriaxone. Further work up revealed rhabdomyolysis, elevated lactate, and unremarkable imaging.

Following treatment, the patient’s symptoms improved to resolution with completion of therapy, effectively confirming the diagnosis of tetanus.

## Linked entities

- **Chemicals:** metronidazole (PubChem CID 4173), ceftriaxone (PubChem CID 5479530)
- **Diseases:** tetanus (MONDO:0005526), rhabdomyolysis (MONDO:0005290)

## Full-text entities

- **Diseases:** airway compromise (MESH:D000402), Tetanus (MESH:D013746), stiffness of the masseter muscles (MESH:D014313), rhabdomyolysis (MESH:D012206), death (MESH:D003643), spasms (MESH:D013035), infectious disease (MESH:D003141)
- **Chemicals:** lactate (MESH:D019344), metronidazole (MESH:D008795), ceftriaxone (MESH:D002443)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12097271/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12097271/full.md

---
Source: https://tomesphere.com/paper/PMC12097271